ATE365539T1 - Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten - Google Patents

Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten

Info

Publication number
ATE365539T1
ATE365539T1 AT00990351T AT00990351T ATE365539T1 AT E365539 T1 ATE365539 T1 AT E365539T1 AT 00990351 T AT00990351 T AT 00990351T AT 00990351 T AT00990351 T AT 00990351T AT E365539 T1 ATE365539 T1 AT E365539T1
Authority
AT
Austria
Prior art keywords
membrane protein
integral membrane
transmembrane domains
proteoliposome
proteoliposomes containing
Prior art date
Application number
AT00990351T
Other languages
English (en)
Inventor
Joseph Sodroski
Tajib Mirzabekov
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE365539T1 publication Critical patent/ATE365539T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00990351T 1999-12-30 2000-12-27 Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten ATE365539T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17367599P 1999-12-30 1999-12-30
US20759600P 2000-05-26 2000-05-26

Publications (1)

Publication Number Publication Date
ATE365539T1 true ATE365539T1 (de) 2007-07-15

Family

ID=26869421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990351T ATE365539T1 (de) 1999-12-30 2000-12-27 Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten

Country Status (7)

Country Link
US (1) US6761902B2 (de)
EP (1) EP1246607B1 (de)
AT (1) ATE365539T1 (de)
CA (1) CA2395882C (de)
DE (1) DE60035369T2 (de)
ES (1) ES2288886T3 (de)
WO (1) WO2001049265A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059031A1 (en) * 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
EP2085781B2 (de) * 2000-10-06 2020-03-11 Life Technologies Corporation Zellen mit spektralen Signaturen und Verfahren zur Herstellung und Verwendung davon
CA2431212A1 (en) * 2000-12-27 2002-07-25 Richard T. Wyatt Immunogenic proteoliposomes, and uses thereof
US20030129666A1 (en) * 2001-01-09 2003-07-10 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor
WO2004031759A1 (ja) * 2002-10-04 2004-04-15 Protosera Inc. 質量分析用プレート、その調製方法およびその用途
AU2002351239A1 (en) * 2001-12-04 2003-06-17 Dana-Farber Cancer Institute, Inc. Antibody to latent membrane proteins and uses thereof
EP1447080A1 (de) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Methode zur Herstellung von Virosomen-artigen Partikeln
US20060210549A1 (en) * 2004-09-10 2006-09-21 Srivastava Devendra K Controlled release liposomes and methods of use
EP1831247B1 (de) 2004-12-29 2009-07-01 Seattle Biomedical Research Institute Hetero-oligomere hiv-hüllproteine
CA2597717C (en) 2005-02-18 2014-10-21 Dana-Farber Cancer Institute Antibodies against cxcr4 and methods of use thereof
US7857978B2 (en) * 2005-05-20 2010-12-28 Aquaporin A/S Membrane for filtering of water
WO2007092457A2 (en) * 2006-02-06 2007-08-16 Msm Protein Technologies Ligands for virus channel proteins
WO2008012062A1 (en) * 2006-07-24 2008-01-31 Polymun Scientific Immunbiologische Forschung Gmbh Antigenic proteoliposomes and method of manufacture
ES2625798T3 (es) 2006-10-02 2017-07-20 E. R. Squibb & Sons, L.L.C. Anticuerpos humanos que se unen a CXCR4 y usos de los mismos
GB0700914D0 (en) * 2007-01-18 2007-02-28 Animal Health Inst Polynucleotides and uses thereof
US20100189777A1 (en) * 2007-07-20 2010-07-29 Basf Se Functionalized nanocompartments with a transport system
US8378003B2 (en) * 2007-12-05 2013-02-19 The Board Of Trustees Of The University Of Illinois Highly permeable polymeric membranes
KR101007308B1 (ko) 2008-02-29 2011-01-13 재단법인서울대학교산학협력재단 계면활성제를 이용한 g 단백질 연결 수용체 단백질정제방법
WO2010027488A2 (en) 2008-09-04 2010-03-11 Vet Therapeutics, Inc. Monoclonal antibodies
WO2010040353A2 (en) 2008-10-07 2010-04-15 Danfoss Aquaz A/S Biomimetic membrane formed from a vesicle-thread conjugate
DK2393481T3 (da) * 2009-02-03 2019-07-15 Applied Biomimetic As Nanofabrikeret membran med polymeriserede proteoliposomer
US8647853B2 (en) 2009-12-15 2014-02-11 Ensovi, Llc Foam microreactor for multi-phase shear-sensitive reactions
JP5911813B2 (ja) 2010-03-04 2016-04-27 ベット・セラピューティクス・インコーポレイテッドVet Therapeutics Inc. Cd20に対するモノクローナル抗体
EP2542258A4 (de) 2010-03-04 2013-08-21 Vet Therapeutics Inc Auf cd52 gerichtete monoklonale antikörper
CA2881605A1 (en) * 2012-08-14 2014-02-20 Aaron FROESE Internal structured self assembling liposomes
EP2746772B1 (de) 2012-12-20 2016-03-23 AIT Austrian Institute of Technology GmbH Lipidmembran-umhüllte Partikel mit Membranproteinen
GB201300465D0 (en) 2013-01-11 2013-02-27 Aquaporin As A hollow fiber module having tfc-aquaporin modified membranes
DK177696B1 (en) 2013-02-25 2014-03-17 Aquaporin As Systems for water extraction
WO2015174978A1 (en) * 2014-05-15 2015-11-19 R-Pharm Overseas, Inc. Antibodies against human receptor integrin alpha-4
KR102002045B1 (ko) * 2017-11-16 2019-07-19 한국세라믹기술원 MtrCAB 단백질이 삽입된 프로테오리포좀 및 그 제조방법
KR102002046B1 (ko) * 2017-11-16 2019-07-19 한국세라믹기술원 친수성 물질을 운반할 수 있는 프로테오리포좀 및 그 제조방법
CN110302373A (zh) * 2019-07-01 2019-10-08 大连民族大学 利用跨膜区定向排列病毒包膜蛋白疫苗及其制备方法
CN110327462A (zh) * 2019-07-01 2019-10-15 大连民族大学 一种脂质体疫苗及其制备方法
CN113433195B (zh) * 2020-03-20 2023-04-07 南京理工大学 使用五甘醇单八烷基醚进行膜蛋白复合物的非变性质谱分析方法
CN113433197B (zh) * 2020-03-20 2023-04-07 南京理工大学 使用四甘醇单十烷基醚进行膜蛋白复合物的非变性质谱分析方法
CN113433196B (zh) * 2020-03-20 2023-04-07 南京理工大学 使用九甘醇单十二烷基醚进行膜蛋白复合物的非变性质谱分析方法
CN113433198B (zh) * 2020-03-20 2023-04-07 南京理工大学 使用六甘醇单八烷基醚进行膜蛋白复合物的非变性质谱分析方法
CN113433199B (zh) * 2020-03-20 2023-05-26 南京理工大学 使用八甘醇单十二烷基醚进行膜蛋白复合物的非变性质谱分析方法
US20220378940A1 (en) * 2021-05-27 2022-12-01 Northwestern University Phase-segregated vesicles for spatially controlled protein-conjugation and cell therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135647A (en) * 1983-02-15 1984-09-05 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US7763258B2 (en) * 1997-05-20 2010-07-27 The Trustees Of The University Of Pennsylvania Virus-like particles (VLPs) comprising heterologous multiple membrane spanning proteins

Also Published As

Publication number Publication date
CA2395882C (en) 2012-07-17
US6761902B2 (en) 2004-07-13
EP1246607B1 (de) 2007-06-27
WO2001049265A1 (en) 2001-07-12
US20010034432A1 (en) 2001-10-25
EP1246607A4 (de) 2004-06-30
CA2395882A1 (en) 2001-07-12
DE60035369D1 (de) 2007-08-09
EP1246607A1 (de) 2002-10-09
DE60035369T2 (de) 2008-02-28
ES2288886T3 (es) 2008-02-01

Similar Documents

Publication Publication Date Title
DE60035369D1 (de) Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten
DE3765013D1 (de) Kuenstliche gefaesswand.
CO4810339A1 (es) Nuevas estructuras artificiales de proteinas de fusion y metodo de preparacion
DE69637102D1 (de) Kartenanzeigegerät mit künstlichem Hintergrund
MX9304363A (es) Metodo para enlace intracelular de moleculas blanco.
ATE297982T1 (de) Immortalisierter fusionspartner von kaninchen
CA2056279A1 (en) Cell-free receptor binding assays, the production and use thereof
ES2098800T3 (es) Compuestos termoplasticos de varias capas.
ATE412432T1 (de) Internalisierende erbb2 antikörper
DE69621488D1 (de) Karaokevorrichtung mit Erzegung von einer an eine Gesangstimme zugefügten synthetischen Stimme
ES8802197A1 (es) Procedimiento de analisis inmunologicos de proteina amiloide a de suero (saa) y-o componente amiloide p se suero (sap)
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
EP0745843A3 (de) Elektrochemischer Immunobiosensor
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
ES2131690T3 (es) Dispositivo para la dosificacion de haptenos y su utilizacion.
DE69914786D1 (de) Leder beschichtet mit fluorharz
DE3884731D1 (de) Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin.
AR016681A1 (es) Deplecion de celulas th2; composiciones; metodos
ATE215598T1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
NO20004649D0 (no) Modulatorer av funksjonen av reseptorer av TNF/NGF- reseptorfamilien og andre proteiner
ATE89924T1 (de) Mit der faehigkeit zur lokalisation von objekten ausgestattete liposomen und ihre verwendung in einem immunoassay.
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
ES2158390T3 (es) Compuestos colorantes y metodos para su fabricacion.
KR860003120A (ko) 박공예에서의 종합예비 가공 재배방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties